Lucence

Lucence is a precision oncology company that specializes in non-invasive liquid biopsy tests for cancer detection and treatment selection. By utilizing advanced technologies, including sequencing and cellular imaging, Lucence aims to identify the hallmarks of cancer at an earlier stage. The company's total liquid biopsy approach focuses on profiling cancer through the analysis of circulating tumor DNA and RNA, allowing healthcare professionals to enhance the accuracy and affordability of cancer diagnosis and treatment planning.